Dear Editor,
We would like to discuss the article “COVID-19 Infection Risk Following Elective Arthroplasty and Surgical Complications in COVID-19 Vaccinated Patients: A Multicenter Comparative Cohort Study [
[1]
].” The immunization, according to Mirghaderi et al., does not guarantee that a patient would not get COVID-19 following an arthroplasty surgery, especially in an area with a high risk of COVID-19. We believe that moderate COVID-19 measures may be necessary even in vaccinated patients [[1]
].We can all agree that providing a COVID-19 vaccine is a fantastic idea. Several factors, such as the vaccinee's past comorbidity, the kind of COVID-19, the manner of vaccine administration, and the local epidemiology of severe acute respiratory syndrome coronavirus 2, should be considered. In the absence of clinical signs, the prevalent occurrence of asymptomatic COVID-19 could also play a role [
[2]
]. Testing is frequently skipped to rule out a previous, asymptomatic COVID-19 infection. Only having a history of previous illnesses is insufficient. Laboratory testing must be performed as needed. To better identify the underlying immunological difficulties that a vaccine recipient is experiencing, certain laboratory testing should be used. Examining the underlying immunological abnormalities of vaccination recipients on a regular basis helps one to forecast the efficacy of the COVID-19 vaccine.This is an important consideration when determining the efficacy or safety of a vaccination.
Despite the fact that data on prevaccination health or immunological status are occasionally lacking, various clinical articles have demonstrated the efficacy, safety, or clinical significance of the COVID-19 vaccine. Furthermore, the possibility of cross-contamination with an undetected severe acute respiratory syndrome coronavirus 2 infection cannot be completely eliminated. Another recent study [
[3]
] discovered a relationship between inherited genetic variation and vaccine recipients' immunological reaction. If additional research is planned, the impact of the genetic polymorphism should be assessed.Conflicts of interest
The authors declare there are no conflicts of interest.
For full disclosure statements refer to https://doi.org/10.1016/j.artd.2022.10.014.
Appendix A. Supplementary Data
- Conflict of Interest Statement for All Authors
References
- COVID-19 infection risk following elective arthroplasty and surgical complications in COVID-19 vaccinated patients: a multicenter comparative Cohort study.Arthroplast Today. 2022; 18: 76-83https://doi.org/10.1016/j.artd.2022.09.005
- Letter to the editor: coronavirus disease 2019 (COVID-19), infectivity, and the incubation period.J Prev Med Public Health. 2020; 53: 70
- GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine.Front Genet. 2022; 13: 932043
Article info
Publication history
Published online: November 03, 2022
Accepted:
October 5,
2022
Received:
October 3,
2022
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2022 Published by Elsevier Inc. on behalf of The American Association of Hip and Knee Surgeons.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- Response to the Letter to the Editor: “COVID-19 Infection Risk, Elective Arthroplasty and Surgical Complications, and COVID-19 Vaccination: Correspondence”Arthroplasty Today
- PreviewWe would like to thank both Dr. Mungmunpuntipantip for his precise comments on our article [1] and the Editor-in-Chief of Arthroplasty Today for giving us the opportunity to respond. The comments were read with specific interest, and we attempted to respond to our colleague's questions, acknowledging the limitations of the study which could also result in misinterpretation of the results. In the following paragraph, we describe the 3 consecutive studies we published in 2022 about COVID-19 infection after total joint arthroplasty (TJA).
- Full-Text
- Preview
